EUVIMEDEUVIMED entdecken
Leserbrief

Comment on “Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination”

Hinpetch Daungsupawong, Viroj Wiwanitkit

Cutis · 2024

DOI: 10.12788/cutis.1072 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cutis, 2024. Verfasst von Hinpetch Daungsupawong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Daungsupawong is from Private Academic Consultant, Phonhong, Lao People's Democratic Republic. Dr. Wiwanitkit is from the Department of Research …. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Pityriasis Rubra Pilaris.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesPityriasis Rubra PilarisHumansCOVID-19

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Dr. Daungsupawong is from Private Academic Consultant, Phonhong, Lao People's Democratic Republic. Dr. Wiwanitkit is from the Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute o…

Zitieren

APA

Daungsupawong, H., & Wiwanitkit, V. (2024). Comment on “Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination”. Cutis. https://doi.org/10.12788/cutis.1072

Vancouver

Daungsupawong H, Wiwanitkit V. Comment on “Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination”. Cutis. 2024. doi:10.12788/cutis.1072

BibTeX
@article{Daungsupawong2024,
  author = {Daungsupawong, Hinpetch and Wiwanitkit, Viroj},
  title = {Comment on “Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination”},
  journal = {Cutis},
  year = {2024},
  doi = {10.12788/cutis.1072}
}
Kostenlos starten →